Pharmaceutical, medical device and life sciences products are in constant demand.
Litigation presents ongoing risk and quick resolution is critical. Using in-depth analysis, expert medical opinions, reviewing medical literature and applicable law, we develop cost-effective strategies to resolve our cases.
Not only do we help companies assess risk and get the best possible results, we set legal precedent and play an important role in establishing laws that benefit the industry.
We understand the difficulties of shepherding products through clinical trials, regulatory processes and ultimately bringing them to market.
Our unique blend of legal, scientific, technical and market experience includes a wide array of pharmaceutical and medical device products. We’ve resolved numerous spinal implant and latex glove cases without claim payments by our clients.
We’ve also successfully handled many other types of cases, including:
Quick resolutions to disputes are critical to a company’s success and the reputation of its product. We pursue early case disposition whenever possible. If trial is unavoidable, we aggressively defend cases in the courtroom at a national, regional and local level.
Law360 | July 24, 2020
Complex Commercial Disputes co-practice group leader and Boston partner Steve LaRose and Manchester associate Kierstan Schultz were mentioned in this article for representing Aetna in a suit regarding coverage for medical device manufacturer Conformis’ customized total knee implants.
Law360 | June 25, 2020
This article, covering a federal judge’s dismissal of claims against NP client Bayer Corp. related to the company’s Essure birth control device, mentions Buffalo Complex Commercial Disputes partner Vivian Quinn and counsel Tracey Scarpello for representing Bayer.
Intellectual Property & Technology Law Journal | December 05, 2019
Intellectual Property associates Sydney Pritchett, Ben Rosborough and Ravi Braich authored this patent alert about remaining questions and uncertainty following the U.S. Supreme Court ‘s ruling in Helsinn Healthcare S.A. v. Teva Pharmaceuticals U.S.
Defense Research Institute | September 04, 2019
Complex Commercial Disputes partner Vivian Quinn and associate Tracey Scarpello, both of the Buffalo office, co-wrote this article in the Defense Research Institute’s publication, analyzing the impact of the ascertainability requirement on pharmaceutical and medical device class actions.
Reuters Legal | July 25, 2019
This story mentions Boston Government Investigations and White Collar Defense partner Mark Seltzer for his representation of GlaxoSmithKline in an ongoing matter regarding the drugmaker’s antinausea medication, Zofran.
Law360 | July 10, 2019
The following articles mention Boston Government Investigations and White Collar Defense partners Mark Seltzer and Brian French for their representation of GlaxoSmithKline in an ongoing matter related to the pharmaceutical company’s anti-nausea drug Zofran. One of the issues is whether federal law pre-empts state law in the case.
Reuters Legal | July 10, 2019
The following articles mention Boston Government Investigations and White Collar Defense partners Mark Seltzer and Brian French for their representation of GlaxoSmithKline in an ongoing matter related to the pharmaceutical company’s anti-nausea drug Zofran. One of the issues is whether federal law pre-empts state law in the case.
Reuters Legal | June 04, 2019
This article mentions Boston Government Investigations and White Collar Defense partner Mark Seltzer for his representation of GlaxoSmithKline in an ongoing matter related to its anti-nausea medication Zofran.
Reuters Legal | April 02, 2019
Boston Government Investigations & White Collar Defense partner Mark Seltzer is mentioned in this story for his representation of pharmaceutical company GlaxoSmithKline in an ongoing matter related to the company’s anti-nausea drug Zofran.
Reuters | March 05, 2019
Boston Government Investigations and White Collar Defense partner Mark Seltzer is mentioned in this article for representing GlaxoSmithKline in an ongoing dispute related to the company’s anti-nausea drug Zofran.
Law360 | September 12, 2018
Boston Government Investigations & White Collar Defense partners Mark Seltzer and Brian French are mentioned in this article for their ongoing representation of GlaxoSmithKline in a suit regarding their drug Zofran.
Massachusetts Lawyers Weekly | August 27, 2018
Litigation Department head Scott O’Connell is mentioned in this case summary for his role as co-counsel for a group of pharmaceutical companies. The companies successfully defended a suit by a class of customers seeking to force changes to the design of the companies’ eyedrops bottles.
Law360 | August 26, 2018
Nixon Peabody is mentioned in this article as co-counsel for a group of pharmaceutical companies who won dismissal of a First Circuit class-action suit regarding the design of their eyedrop bottles.
Law360 | April 25, 2018
Albany commercial litigation partner Bill Reynolds is mentioned in this story for his representation of AngioDynamics Inc. in an ongoing dispute with Biolitec AG.
Law360 | April 24, 2018
Boston government investigations and white collar defense partners Mark Seltzer and Brian French are mentioned in this story for their representation of pharmaceutical company GlaxoSmithKline in a lawsuit brought by users of its anti-nausea medication Zofran.
Partner
Leader, Medical Device, Pharmaceuticals and Diagnostic Health
Phone: 312-977-4460
Associate
Deputy Leader, Medical Device, Pharmaceuticals and Diagnostic Health
Phone: 312-977-4361
